Effect of a combined treatment with erythropoietin and melatonin on renal ischemia reperfusion injury in male rats.

Background: Renal ischemia reperfusion (IR) is an important cause of renal dysfunction. It contributes to the development of acute renal failure. Oxidative damage from reactive oxygen species is considered to be the principal component involved in the pathophysiological tissue alterations observed during IR.